267 related articles for article (PubMed ID: 16166937)
1. Sentinel lymph node biopsy. Preferred method of axillary staging for breast cancer.
Tuttle TM
Minerva Ginecol; 2005 Jun; 57(3):293-303. PubMed ID: 16166937
[TBL] [Abstract][Full Text] [Related]
2. Sentinel lymph node biopsy examination for breast cancer patients with clinically negative axillary lymph nodes after neoadjuvant chemotherapy.
Kinoshita T; Takasugi M; Iwamoto E; Akashi-Tanaka S; Fukutomi T; Terui S
Am J Surg; 2006 Feb; 191(2):225-9. PubMed ID: 16442950
[TBL] [Abstract][Full Text] [Related]
3. Feasibility and accuracy of sentinel lymph node biopsy after preoperative chemotherapy in breast cancer patients with documented axillary metastases.
Shen J; Gilcrease MZ; Babiera GV; Ross MI; Meric-Bernstam F; Feig BW; Kuerer HM; Francis A; Ames FC; Hunt KK
Cancer; 2007 Apr; 109(7):1255-63. PubMed ID: 17330229
[TBL] [Abstract][Full Text] [Related]
4. ICG fluorescence-guided sentinel node biopsy for axillary nodal staging in breast cancer.
Hirche C; Murawa D; Mohr Z; Kneif S; Hünerbein M
Breast Cancer Res Treat; 2010 Jun; 121(2):373-8. PubMed ID: 20140704
[TBL] [Abstract][Full Text] [Related]
5. Sentinel lymph node biopsy using periareolar injection of radiocolloid for patients with neoadjuvant chemotherapy-treated breast carcinoma.
Shimazu K; Tamaki Y; Taguchi T; Akazawa K; Inoue T; Noguchi S
Cancer; 2004 Jun; 100(12):2555-61. PubMed ID: 15197796
[TBL] [Abstract][Full Text] [Related]
6. Clinical impact of false-negative sentinel lymph nodes in breast cancer.
Zavagno G; Del Bianco P; Koussis H; Artioli G; Carraro P; De Salvo GL; Mencarelli R; Belardinelli V; Marconato G; Nitti D
Eur J Surg Oncol; 2008 Jun; 34(6):620-5. PubMed ID: 17764888
[TBL] [Abstract][Full Text] [Related]
7. Validation of subareolar and periareolar injection techniques for breast sentinel lymph node biopsy.
Chagpar A; Martin RC; Chao C; Wong SL; Edwards MJ; Tuttle T; McMasters KM
Arch Surg; 2004 Jun; 139(6):614-8; discussion 618-20. PubMed ID: 15197087
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive axillary evaluation in neoadjuvant chemotherapy patients with ultrasonography and sentinel lymph node biopsy.
Khan A; Sabel MS; Nees A; Diehl KM; Cimmino VM; Kleer CG; Schott AF; Hayes DF; Chang AE; Newman LA
Ann Surg Oncol; 2005 Sep; 12(9):697-704. PubMed ID: 16079956
[TBL] [Abstract][Full Text] [Related]
9. Intradermal isotope injection is superior to intramammary in sentinel node biopsy for breast cancer.
Martin RC; Derossis AM; Fey J; Yeung H; Yeh SD; Akhurst T; Heerdt AS; Petrek J; VanZee KJ; Montgomery LL; Borgen PI; Cody HS
Surgery; 2001 Sep; 130(3):432-8. PubMed ID: 11562666
[TBL] [Abstract][Full Text] [Related]
10. A Randomized clinical trial on sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer: results of the Sentinella/GIVOM trial.
Zavagno G; De Salvo GL; Scalco G; Bozza F; Barutta L; Del Bianco P; Renier M; Racano C; Carraro P; Nitti D;
Ann Surg; 2008 Feb; 247(2):207-13. PubMed ID: 18216523
[TBL] [Abstract][Full Text] [Related]
11. Determination of sentinel lymph node (SLN) status in primary breast cancer by prospective use of immunohistochemistry increases the rate of micrometastases and isolated tumour cells: analysis of 174 patients after SLN biopsy.
Rydén L; Chebil G; Sjöström L; Pawlowski R; Jönsson PE
Eur J Surg Oncol; 2007 Feb; 33(1):33-8. PubMed ID: 17174513
[TBL] [Abstract][Full Text] [Related]
12. Sentinel lymph node biopsy is associated with improved survival compared to level I & II axillary lymph node dissection in node negative breast cancer patients.
Langer I; Guller U; Hsu-Schmitz SF; Ladewig A; Viehl CT; Moch H; Wight E; Harder F; Oertli D; Zuber M
Eur J Surg Oncol; 2009 Aug; 35(8):805-13. PubMed ID: 19046846
[TBL] [Abstract][Full Text] [Related]
13. Axillary recurrences after negative sentinel lymph node biopsy under local anaesthesia for breast cancer: a follow-up study after 5 years.
Groetelaers RP; van Berlo CL; Nijhuis PH; Schapers RF; Gerritsen HA
Eur J Surg Oncol; 2009 Feb; 35(2):159-63. PubMed ID: 18789841
[TBL] [Abstract][Full Text] [Related]
14. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
[TBL] [Abstract][Full Text] [Related]
15. Morbidity in breast cancer patients with sentinel node metastases undergoing delayed axillary lymph node dissection (ALND) compared with immediate ALND.
Goyal A; Newcombe RG; Chhabra A; Mansel RE
Ann Surg Oncol; 2008 Jan; 15(1):262-7. PubMed ID: 17879117
[TBL] [Abstract][Full Text] [Related]
16. Complement of peritumoral and subareolar injection in breast cancer sentinel lymph node biopsy.
Noguchi M; Inokuchi M; Zen Y
J Surg Oncol; 2009 Aug; 100(2):100-5. PubMed ID: 19479943
[TBL] [Abstract][Full Text] [Related]
17. Axillary management after sentinel lymph node biopsy in breast cancer patients.
Rivers A; Hansen N
Surg Clin North Am; 2007 Apr; 87(2):365-77, ix. PubMed ID: 17498532
[TBL] [Abstract][Full Text] [Related]
18. Axillary reverse mapping: mapping and preserving arm lymphatics may be important in preventing lymphedema during sentinel lymph node biopsy.
Boneti C; Korourian S; Bland K; Cox K; Adkins LL; Henry-Tillman RS; Klimberg VS
J Am Coll Surg; 2008 May; 206(5):1038-42; discussion 1042-4. PubMed ID: 18471751
[TBL] [Abstract][Full Text] [Related]
19. Current controversies concerning sentinel lymph node biopsy for breast cancer.
Noguchi M
Breast Cancer Res Treat; 2004 Apr; 84(3):261-71. PubMed ID: 15026624
[TBL] [Abstract][Full Text] [Related]
20. Detection of the sentinel lymph node in breast cancer.
Somasundaram SK; Chicken DW; Keshtgar MR
Br Med Bull; 2007; 84():117-31. PubMed ID: 18174216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]